Cargando…

Case Report: Gastrointestinal PEComa With TFE3 Rearrangement Treated With Anti-VEGFR TKI Apatinib

Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal tumors. Unresectable malignant PEComas with TFE3 rearrangement have no recommended therapy to date. Here, we report the first case of malignant gastrointestinal PEComa with TFE3 rearrangement which has a response to the targeted the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jiaming, Gong, Xiao-Lei, Wu, Huanwen, Zhao, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719820/ https://www.ncbi.nlm.nih.gov/pubmed/33330059 http://dx.doi.org/10.3389/fonc.2020.582087

Ejemplares similares

Primary Xp11 translocation PEComa of the testis with SFPQ⁃TFE3 rearrangement: a case report and review of the literature
por: Zhang, Huizhi, et al.
Publicado: (2023)

TFE3-rearranged renal cell carcinoma with osseous metaplasia and indolent behaviour
por: Aldera, Alessandro Pietro, et al.
Publicado: (2022)

Uterine perivascular epithelioid tumors (PEComas) with lung metastasis showed good responses to mTOR and VEGFR inhibitors: A case report
por: Sui, Chengxu, et al.
Publicado: (2022)

Uterine PEComas: Correlation Between Melanocytic Marker Expression and TSC Alterations/TFE3 Fusions
por: Bennett, Jennifer A., et al.
Publicado: (2022)

VEGFR Inhibitors for Uterine Metastatic Perivascular Epithelioid Tumors (PEComa) Resistant to mTOR Inhibitors. A Case Report and Review of Literature
por: Liapi, Aikaterini, et al.
Publicado: (2021)

Apatinib Treatment in Metastatic Gastrointestinal Stromal Tumor
por: Cai, Zhaolun, et al.
Publicado: (2019)

TFE3-rearranged renal cell carcinoma with tumour thrombus in the ureter mimicking invasive transitional cell carcinoma
por: Chacko, Arman Z., et al.
Publicado: (2023)

TFE3 activation in a TSC1‐altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms
por: Schmiester, Maren, et al.
Publicado: (2020)

Retroperitoneal PEComa: Case report and review of literature
por: Singer, Eric, et al.
Publicado: (2018)

Xp11.2 Translocation Renal Cell Carcinoma With TFE3 Rearrangement: Distinct Morphological Features and Prognosis With Different Fusion Partners
por: Ge, Yan, et al.
Publicado: (2021)

Bladder PEComa: A case report and literature review
por: Tian, Chuan, et al.
Publicado: (2019)

Management of VEGFR-Targeted TKI for Thyroid Cancer
por: Enokida, Tomohiro, et al.
Publicado: (2021)

Anti-Tumor Effect of Apatinib and Relevant Mechanisms in Liposarcoma
por: Cui, Lixuan, et al.
Publicado: (2021)

A safe and effective treatment combination of neoadjuvant therapy and surgical resection for metastatic TFE3-rearranged renal cell carcinoma:a case report
por: Yang, Haiyang, et al.
Publicado: (2023)

Hepatic YAP1-TFE3 Rearranged Epithelioid Hemangioendothelioma
por: Lotfalla, Mira M., et al.
Publicado: (2019)

Malignant Perivascular Epithelioid Cell Neoplasm (PEComa) of the Pelvis: A Case Report
por: D'Andrea, David, et al.
Publicado: (2016)

Case Report: A Novel Pathomechanism in PEComa by the Loss of Heterozygosity of TP53
por: Butz, Henriett, et al.
Publicado: (2022)

A Liver Transplant for Local Control in a Pediatric Patient with Metastatic TFE3-Associated Perivascular Epithelioid Cell Tumor (PEComa) to the Liver
por: Lee, Whayoung, et al.
Publicado: (2021)

Lingual alveolar soft part sarcoma with absent TFE3 rearrangement
por: Alshahrani, Saeed, et al.
Publicado: (2020)

Clinicopathological features and prognosis of TFE3-positive renal cell carcinoma
por: Dong, Xiang, et al.
Publicado: (2022)

Study of Cathepsin B inhibition in VEGFR TKI treated human renal cell carcinoma xenografts
por: Chen, Chun-Hau, et al.
Publicado: (2019)

Case report: Kidney perivascular epithelioid cell tumor treated with anti-VEGFR tyrosine kinase inhibitor and MTOR inhibitor
por: Zhang, Ninggang, et al.
Publicado: (2022)

Malignant lung PEComa (clear cell tumor): rare case report and literature review
por: Campos, Marcos Adriano Garcia, et al.
Publicado: (2023)

Case report: Epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib
por: Li, Mengmeng, et al.
Publicado: (2023)

Unique presentation of retroperitoneal malignant perivascular epithelioid cell tumor (PEComa) in a young male
por: Freeman, Ryan, et al.
Publicado: (2022)

Anti-PD-1 immunotherapy combined with stereotactic body radiation therapy and GM-CSF for the treatment of advanced malignant PEComa: A case report
por: Wang, Yunfan, et al.
Publicado: (2023)

Activity and safety of apatinib monotherapy or apatinib combined with chemotherapy for patients with metastatic or unresectable osteosarcoma over the age of 40 years: A retrospective analysis
por: Gong, Taojun, et al.
Publicado: (2022)

Apatinib-Induced Hand–Foot Skin Reaction in Chinese Patients With Liver Cancer
por: Xia, Hui, et al.
Publicado: (2021)

Uterine collision tumor (PEComa and endometrioid carcinoma) in a tuberous sclerosis patient: a case report
por: Koufopoulos, Nektarios, et al.
Publicado: (2023)

Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety
por: Liao, Zhichao, et al.
Publicado: (2019)

Apatinib Induces Ferroptosis of Glioma Cells through Modulation of the VEGFR2/Nrf2 Pathway
por: Xia, Liang, et al.
Publicado: (2022)

Epithelioid hemangioendotheliomas with TFE3 gene translocations are compossible with CAMTA1 gene rearrangements
por: Lee, Seok Joo, et al.
Publicado: (2016)

Novel Nutrition-Based Nomograms to Assess the Outcomes of Lung Cancer Patients Treated With Anlotinib or Apatinib
por: Zheng, Hui, et al.
Publicado: (2021)

Apatinib inhibits VEGFR-2 and angiogenesis in an in vivo murine model of nasopharyngeal carcinoma
por: Peng, Qiu-Xia, et al.
Publicado: (2017)

Aneurysm and Artery Dissection After Oral VEGFR-TKI Use in Adults With Cancer
por: Kang, Soyoung, et al.
Publicado: (2023)

Low dose of apatinib in treating chemotherapy and EGFR-TKI refractory non-small cell lung cancer: A case report
por: Liu, Jin, et al.
Publicado: (2019)

Primary Tumor Resection Improves Survival for EGFR-TKI-Treated Patients With Occult M1a Lung Adenocarcinoma
por: Fu, Fangqiu, et al.
Publicado: (2021)

Alveolar soft part sarcoma of lung: report of a unique case with emphasis on diagnostic utility of molecular genetic analysis for TFE3 gene rearrangement and immunohistochemistry for TFE3 antigen expression
por: Zhao, Ming, et al.
Publicado: (2015)

Apatinib monotherapy for advanced VEGFR-2-negative nasopharyngeal carcinoma: A case report
por: Jin, Jun, et al.
Publicado: (2019)

Treatment Response, Survival Benefit and Safety Profile of PD-1 Inhibitor Plus Apatinib Versus Apatinib Monotherapy in Advanced Colorectal Cancer Patients
por: Pan, Dengdeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3e07pcgphtke3o41d6a5j1ef68